Related Experiment Video
Updated: Apr 5, 2026
06:36
An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices
Published on: February 5, 2015
7.6K
Immunopathology of multiple sclerosis.
Calliope A Dendrou1, Lars Fugger1,2, Manuel A Friese3
1Nuffield Department of Clinical Neurosciences, Division of Clinical Neurology and MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DS, UK.
Nature Reviews. Immunology
|August 8, 2015
Summary
Decades of immunomodulatory treatments reveal distinct immune pathways in multiple sclerosis (MS). Understanding MS immunopathology and inflammation
Area of Science:
- Immunology
- Neuroscience
- Clinical Medicine
Background:
- Multiple sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system.
- Immunomodulatory treatments have been used for two decades to manage MS.
- Distinct immunological pathways are implicated in MS relapses and progression.
Purpose of the Study:
- To review current understanding of MS immunopathology.
- To evaluate hypotheses on the immune system's role in MS.
- To identify unanswered questions in MS research.
Main Methods:
- Literature review of clinical experience with immunomodulatory treatments.
- Analysis of immunological pathways in MS.
- Discussion of recent advances in immunology and neurodegeneration.
Main Results:
- Immunomodulatory treatments highlight specific immune mechanisms in MS.
- Inflammation is increasingly recognized as a key factor in neurodegeneration.
- Current understanding of MS pathophysiology is evolving.
Conclusions:
- Further research is needed to address unanswered questions in MS.
- Advances in immunology and neurodegeneration research will refine MS conceptualization.
- Improved understanding may lead to enhanced patient care for multiple sclerosis.
Related Concept Videos
01:24T Cell Types and Functions
3.3K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.3K
01:40Cell-mediated Immune Responses
86.6K
Overview
86.6K